0%
0 / 13 answered

English Language Arts: Combining Sources (TEKS.ELA.9-12.12.F) Practice Test

13 Questions
Question
1 / 13
Q1

Source A (Ecology and Evolution): Recent modeling and empirical lab trials of CRISPR-based gene drives targeting disease-vector mosquitoes (e.g., Anopheles, Aedes) reveal complex population dynamics. Resistance alleles arise via non-homologous end joining, often restoring fertility and slowing spread. Spatial structure and gene flow across heterogeneous habitats create threshold effects: below certain frequencies, drives fail to invade; above them, suppression can be rapid but uneven. Non-target ecological effects remain uncertain, including potential niche replacement by other vector species. Accordingly, technical assessments advocate a phased testing pathway—from contained laboratory work to small, reversible field trials—paired with ecological monitoring and clear criteria for pause or rollback. The precautionary principle does not imply prohibition but demands adaptive management, transparency, and international coordination to handle transboundary dispersal and shared ecosystems.

Source B (Global Health Policy): Vector-borne diseases impose high mortality and economic costs in low-resource regions where insecticide resistance and limited health infrastructure undermine traditional control. Comparative cost-effectiveness analyses suggest that, if efficacious, gene drive–enabled suppression could reduce transmission at lower recurrent cost than blanket spraying, especially when integrated with bed nets, targeted larviciding, and improved case management. Public health ethics frameworks stress procedural justice: community engagement, informed collective consent, and benefit sharing with affected populations. Modeling studies show that even partial reductions in vector density can yield nonlinear declines in malaria or dengue incidence when combined with surveillance and rapid treatment. However, governance questions persist: who authorizes release, how success is measured, and how liabilities are handled. Proponents argue pilot deployments should proceed where disease burden is severe and alternatives are failing, provided oversight is robust and locally legitimated.

After reading both sources, which synthesis best combines their insights into a nuanced, accurate conclusion?

Question Navigator